No black box warning on record for Sulfameth/trimeth-Ds

As of the latest FDA labeling reviewed, Sulfameth/trimeth-Ds (SULFAMETH/TRIMETH-DS) does not carry a black box warning. Standard warnings and precautions still apply — see the full Sulfameth/trimeth-Ds medicine page for the complete safety profile.

Other warnings & precautions

Embryofetal Toxicity Some epidemiologic studies suggest that exposure to sulfamethoxazole and trimethoprim during pregnancy may be associated with an increased risk of congenital malformations, particularly neural tube defects, cardiovascular malformations, urinary tract defects, oral clefts, and club foot. If sulfamethoxazole and trimethoprim is used during pregnancy, or if the patient becomes pr

No black box warning on record for Sulfameth/trimeth-Ds

Other warnings & precautions

Embryofetal Toxicity Some epidemiologic studies suggest that exposure to sulfamethoxazole and trimethoprim during pregnancy may be associated with an increased risk of congenital malformations, particularly neural tube defects, cardiovascular malformations, urinary tract defects, oral clefts, and club foot. If sulfamethoxazole and trimethoprim is used during pregnancy, or if the patient becomes pr

Sulfameth/trimeth-Ds Black Box Warning

No black box warning on record for Sulfameth/trimeth-Ds

Other warnings & precautions

Sulfameth/trimeth-Ds Black Box Warning

No black box warning on record for Sulfameth/trimeth-Ds

Other warnings & precautions